Home › Trial NCT00003294
Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer
- Trial IDNCT00003294
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorRoswell Park Cancer Institute
- Enrollment24
- Start date1997-05
- ConditionsLeukemia · Lymphoma · Unspecified Adult Solid Tumor, Protocol Specific
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.